| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5c0fe15b889e6e1a4e435a0a9f5426d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3a7c371aff1d99f0097896d0ec9f6c86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4473045c6843c83bed6e99c9202b557 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-473
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate |
2008-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80fc6c8383db7c1421fa4cf600d67b95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7355da8ed63d5b451e032306567f2f10 |
| publicationDate |
2012-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8309108-B2 |
| titleOfInvention |
Intranasal compositions |
| abstract |
A liquid aqueous formulation for the intranasal administration of apomorphine includes:n (a) at least about 15 mg/ml of apomorphine; and (b) a solubilising agent selected fromn (i) at least one polyoxyethylene-polyoxypropylene copolymer (poloxamer); (ii) at least one cyclodextrin; and (iii) at least one cyclodextrin together with chitosan.n nThe formulations of the invention can be used in the treatment or management of Parkinson's disease and erectile dysfunction. |
| priorityDate |
2007-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |